Microfluidic technologies for accelerating the clinical translation of nanoparticles

Using nanoparticles for therapy and imaging holds tremendous promise for the treatment of major diseases such as cancer. However, their translation into the clinic has been slow because it remains difficult to produce nanoparticles that are consistent 'batch-to-batch', and in sufficient qu...

Full description

Bibliographic Details
Main Authors: Langer, Robert, Valencia, Pedro Miguel, Farokhzad, Omid C., Karnik, Rohit
Other Authors: MIT-Harvard Center for Cancer Nanotechnology Excellence
Format: Article
Language:en_US
Published: Nature Publishing Group 2013
Online Access:http://hdl.handle.net/1721.1/79399
https://orcid.org/0000-0003-0588-9286
https://orcid.org/0000-0002-2640-3006
https://orcid.org/0000-0003-4255-0492